Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia Di

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
Molecular Cell|July 5, 2017
BET Bromodomain Proteins Function as Master Transcription Elongation Factors Independent of CDK9 RecruitmentGeorg E Winter, Andreas Mayer, Dennis L Buckley, et al.
Biorxiv : the Preprint Server for Biology|November 16, 2022
Towards increased accuracy and reproducibility in SARS-CoV-2 next generation sequence analysis for public health surveillanceRyan Connor, David A Yarmosh, Wolfgang Maier, et al.
Viruses|March 28, 2024
Recommendations for Uniform Variant Calling of SARS-CoV-2 Genome Sequence across Bioinformatic WorkflowsRyan Connor, Migun Shakya, David A Yarmosh, et al.
Biorxiv : the Preprint Server for Biology|April 6, 2021
SARS-CoV-2 immune evasion by variant B.1.427/B.1.429Matthew McCallum, Jessica Bassi, Anna De Marco, et al.
Journal of Hepatology|August 29, 2025
Engineered monoclonal antibody tobevibart enhances HBsAg capture by Fc receptor-positive cells and activates HBV-specific T cellsLucia Vincenzetti, Rachel Wong, Roberta Marzi, et al.
Science (New York, N.Y.)|July 2, 2021
SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concernMatthew McCallum, Jessica Bassi, Anna De Marco, et al.
Nature|July 5, 2023
Author Correction: A pan-influenza antibody inhibiting neuraminidase via receptor mimicryCorey Momont, Ha V Dang, Fabrizia Zatta, et al.
Cell|March 24, 2021
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2Matthew McCallum, Anna De Marco, Florian A Lempp, et al.
Nature|May 31, 2023
A pan-influenza antibody inhibiting neuraminidase via receptor mimicryCorey Momont, Ha V Dang, Fabrizia Zatta, et al.
Biorxiv : the Preprint Server for Biology|January 20, 2021
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2Matthew McCallum, Anna De Marco, Florian Lempp, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Molecular Cell|July 5, 2017
BET Bromodomain Proteins Function as Master Transcription Elongation Factors Independent of CDK9 RecruitmentGeorg E Winter, Andreas Mayer, Dennis L Buckley, et al.
Biorxiv : the Preprint Server for Biology|November 16, 2022
Towards increased accuracy and reproducibility in SARS-CoV-2 next generation sequence analysis for public health surveillanceRyan Connor, David A Yarmosh, Wolfgang Maier, et al.
Viruses|March 28, 2024
Recommendations for Uniform Variant Calling of SARS-CoV-2 Genome Sequence across Bioinformatic WorkflowsRyan Connor, Migun Shakya, David A Yarmosh, et al.
Biorxiv : the Preprint Server for Biology|April 6, 2021
SARS-CoV-2 immune evasion by variant B.1.427/B.1.429Matthew McCallum, Jessica Bassi, Anna De Marco, et al.
Journal of Hepatology|August 29, 2025
Engineered monoclonal antibody tobevibart enhances HBsAg capture by Fc receptor-positive cells and activates HBV-specific T cellsLucia Vincenzetti, Rachel Wong, Roberta Marzi, et al.
Science (New York, N.Y.)|July 2, 2021
SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concernMatthew McCallum, Jessica Bassi, Anna De Marco, et al.
Nature|July 5, 2023
Author Correction: A pan-influenza antibody inhibiting neuraminidase via receptor mimicryCorey Momont, Ha V Dang, Fabrizia Zatta, et al.
Cell|March 24, 2021
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2Matthew McCallum, Anna De Marco, Florian A Lempp, et al.
Nature|May 31, 2023
A pan-influenza antibody inhibiting neuraminidase via receptor mimicryCorey Momont, Ha V Dang, Fabrizia Zatta, et al.
Biorxiv : the Preprint Server for Biology|January 20, 2021
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2Matthew McCallum, Anna De Marco, Florian Lempp, et al.
Pageof 9